Clinical Trials Browser

Lymphoma, B-Cell × brexucabtagene autoleucel × Clear all

NCT06213311 2026-01-14

A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

Phase 2 Recruiting

Lymphoma, B-Cell

NCT02625480 2025-09-29

ZUMA-4

Phase 1/2 Active not recruiting

Recurrence, Lymphoma, B-Cell